Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Chiasserini

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Stem Cell Research & Therapy|January 10, 2026
Molecular and functional characterization of GMP-manufactured neural stem cells and their extracellular vesicles for innovative therapeutic applicationsMartina Guzzetti, Letizia Mezzasoma, Davide Chiasserini, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationPiotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 6, 2023
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation studyMadhurima Chatterjee, Selcuk Özdemir, Marcel Kunadt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 15, 2026
Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry-based proteomicsMarijke E Stokkel, Lisa Vermunt, Jaco C Knol, et al.
Neurobiology of Disease|January 9, 2013
Effects of central and peripheral inflammation on hippocampal synaptic plasticityMassimiliano Di Filippo, Davide Chiasserini, Fabrizio Gardoni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2014
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseLucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, et al.
Blood|August 19, 2022
Donor natural killer cells trigger production of β-2-microglobulin to enhance post-bone marrow transplant immunityLoredana Ruggeri, Elena Urbani, Davide Chiasserini, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
Brain : a Journal of Neurology|March 31, 2019
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alterationValentina Durante, Antonio de Iure, Vittorio Loffredo, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Stem Cell Research & Therapy|January 10, 2026
Molecular and functional characterization of GMP-manufactured neural stem cells and their extracellular vesicles for innovative therapeutic applicationsMartina Guzzetti, Letizia Mezzasoma, Davide Chiasserini, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationPiotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 6, 2023
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation studyMadhurima Chatterjee, Selcuk Özdemir, Marcel Kunadt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 15, 2026
Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry-based proteomicsMarijke E Stokkel, Lisa Vermunt, Jaco C Knol, et al.
Neurobiology of Disease|January 9, 2013
Effects of central and peripheral inflammation on hippocampal synaptic plasticityMassimiliano Di Filippo, Davide Chiasserini, Fabrizio Gardoni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2014
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseLucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, et al.
Blood|August 19, 2022
Donor natural killer cells trigger production of β-2-microglobulin to enhance post-bone marrow transplant immunityLoredana Ruggeri, Elena Urbani, Davide Chiasserini, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
Brain : a Journal of Neurology|March 31, 2019
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alterationValentina Durante, Antonio de Iure, Vittorio Loffredo, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Pageof 9